UK Markets open in 6 hrs 29 mins

Autolus Therapeutics plc (AUTL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.39-0.24 (-3.15%)
At close: 4:00PM EDT
7.50 +0.11 (1.49%)
After hours: 07:55PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5521.05M
Enterprise value 3-6.44M
Trailing P/E N/A
Forward P/E 1-3.87
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)483.12
Price/book (mrq)1.25
Enterprise value/revenue 3-5.98
Enterprise value/EBITDA 70.09

Trading information

Stock price history

Beta (5Y monthly) 1.71
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 317.19
52-week low 34.60
50-day moving average 36.14
200-day moving average 37.21

Share statistics

Avg vol (3-month) 31.3M
Avg vol (10-day) 33.81M
Shares outstanding 570.51M
Implied shares outstanding 6N/A
Float 33.9M
% held by insiders 125.58%
% held by institutions 117.77%
Shares short (14 Apr 2021) 41.28M
Short ratio (14 Apr 2021) 42.67
Short % of float (14 Apr 2021) 4N/A
Short % of shares outstanding (14 Apr 2021) 41.81%
Shares short (prior month 14 Mar 2021) 43.7M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2018

Profitability

Profit margin 0.00%
Operating margin (ttm)-6,570.75%

Management effectiveness

Return on assets (ttm)-22.27%
Return on equity (ttm)-29.62%

Income statement

Revenue (ttm)1.08M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-133.17M
EBITDA -68.94M
Net income avi to common (ttm)-53.28M
Diluted EPS (ttm)-1.40
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)217.45M
Total cash per share (mrq)5.52
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)11.05
Book value per share (mrq)5.91

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A